These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 20509009)
21. Rituximab: a useful drug for a repeatedly relapsed hairy cell leukemia patient. Pollio F; Pocali B; Palmieri S; Morabito P; Scalia G; Del Vecchio L; Ferrara F Ann Hematol; 2002 Dec; 81(12):736-8. PubMed ID: 12483372 [TBL] [Abstract][Full Text] [Related]
22. The pharmacological management of hairy cell leukemia. Ramos Perez J; Ravandi-Kashani F Expert Opin Pharmacother; 2020 Aug; 21(11):1337-1344. PubMed ID: 32378970 [TBL] [Abstract][Full Text] [Related]
23. Hairy cell leukemia: treatment successes in the past 25 years. Golomb HM J Clin Oncol; 2008 Jun; 26(16):2607-9. PubMed ID: 18509168 [No Abstract] [Full Text] [Related]
24. Interferon in the treatment of hairy-cell leukemia. Ahmed S; Rai KR Best Pract Res Clin Haematol; 2003 Mar; 16(1):69-81. PubMed ID: 12670466 [TBL] [Abstract][Full Text] [Related]
25. 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia. Yang MH; Ho CH Zhonghua Yi Xue Za Zhi (Taipei); 2001 Jan; 64(1):54-8. PubMed ID: 11310372 [TBL] [Abstract][Full Text] [Related]
26. Which role for rituximab in hairy cell leukemia? Reflections on six cases. Malfuson JV; Fagot T; Konopacki J; Souleau B; Cremades S; de Revel T Acta Haematol; 2010; 123(2):110-6. PubMed ID: 20051682 [TBL] [Abstract][Full Text] [Related]
27. Long-term follow-up after purine analogue therapy in hairy cell leukaemia. Else M; Dearden CE; Catovsky D Best Pract Res Clin Haematol; 2015 Dec; 28(4):217-29. PubMed ID: 26614900 [TBL] [Abstract][Full Text] [Related]
29. Optimal treatment for untreated patients with hairy cell leukemia? Troussard X; Flandrin G J Clin Oncol; 1995 Oct; 13(10):2677-9. PubMed ID: 7595722 [No Abstract] [Full Text] [Related]
30. Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia. Kreitman RJ; Wilson WH; Bergeron K; Raggio M; Stetler-Stevenson M; FitzGerald DJ; Pastan I N Engl J Med; 2001 Jul; 345(4):241-7. PubMed ID: 11474661 [TBL] [Abstract][Full Text] [Related]
31. Retrospective Evaluation of Hairy Cell Leukemia Patients Treated with Three Different First-Line Treatment Modalities in the Last Two Decades: A Single-Center Experience. Öngören Ş; Eşkazan AE; Berk S; Elverdi T; Salihoğlu A; Ar MC; Başlar Z; Aydın Y; Tüzüner N; Soysal T Turk J Haematol; 2017 Dec; 34(4):291-299. PubMed ID: 29199176 [TBL] [Abstract][Full Text] [Related]